Insider Transactions in Q2 2024 at Royalty Pharma PLC (RPRX)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 28
2024
|
Bonnie L Bassler Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,399
+2.34%
|
$36,374
$26.8 P/Share
|
|
Jun 28
2024
|
Henry A Fernandez Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,399
+2.59%
|
$36,374
$26.8 P/Share
|
|
Jun 07
2024
|
Gregory Norden Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,293
+11.19%
|
-
|
|
Jun 07
2024
|
David C Hodgson Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,293
+26.55%
|
-
|
|
Jun 07
2024
|
Ted W Love Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,293
+16.74%
|
-
|
|
Jun 07
2024
|
Errol B Desouza Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,293
+11.19%
|
-
|
|
Jun 07
2024
|
Catherine M. Engelbert Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,293
+17.6%
|
-
|
|
Jun 07
2024
|
Henry A Fernandez Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,293
+15.35%
|
-
|
|
Jun 07
2024
|
Bonnie L Bassler Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,293
+14.01%
|
-
|
|
May 13
2024
|
Christopher Hite EVP & Vice Chairman |
BUY
Conversion of derivative security
|
Indirect |
300,000
+44.78%
|
-
|